Contraction-induced interleukin-6 transcription in rat slow-type muscle is partly dependent on calcineurin activation

被引:22
作者
Banzet, Sebastien [1 ]
Koulmann, Nathalie [1 ]
Sanchez, Herve [1 ]
Serrurier, Ernard [1 ]
Peinnequin, Andre [1 ]
Alonso, Antonia [1 ]
Bigard, Xavier [1 ]
机构
[1] CRSSA, Dept Human Factors, F-38702 La Tronche, France
关键词
D O I
10.1002/jcp.20854
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
The present work aimed at determining whether interleukin-6 (IL-6) produced by skeletal muscle during exercise is related, at least partly, to calcineurin activity. Rats were treated with two specific calcineurin inhibitors, cyclosporin A (CsA) and FK506, or vehicle (Vhl); they were then subjected to exhaustive treadmill running. Modulatory Calcineurin-Interacting Protein-1 (MCIP-1) mRNA levels, a reliable indicator of calcineurin activity, and IL-6 mRNA levels were measured by real-time RT-PCR in soleus muscles, and IL-6 protein concentration was measured in the plasma. Because low carbohydrates availability enhances IL-6 transcription through p38 Mitogen Activated Protein Kinase (MAPK) pathway, muscle glycogen content and glycaemia were measured and p38 MAPK phosphorylation was determined in skeletal muscle by western blotting. As expected, exercise induced an increase in IL-6 (P < 0.01) and MCIP-1 mRNA (P < 0.01) in soleus muscle of Vhl rats, and enhanced p38 phosphorylation and plasmatic IL-6 protein (P < 0.05). Calcineurin inhibition did not affect running time, glycemia or soleus glycogen content. CsA administration totally inhibited the exercise-induced increase in MCIP-1 rnRNA (P < 0.01), blunted the IL-6 gene transcription related to muscle activity, and suppressed the changes in IL-6 protein in plasma. In addition to its inhibition of calcineurin activity, FK506 administration totally suppressed the exercise-induced IL-6 gene transcription, likely by an inhibition of p38 activation. Taken together, these results demonstrate that in addition to p38 MAPK, increased calcineurin activity is one of the signalling events involved in IL-6 gene transcription.
引用
收藏
页码:596 / 601
页数:6
相关论文
共 37 条
[1]
Evidence that Gαq-coupled receptor-induced interleukin-6 mRNA in vascular smooth muscle cells involves the nuclear factor of activated T cells [J].
Abbott, KL ;
Loss, JR ;
Robida, AM ;
Murphy, TJ .
MOLECULAR PHARMACOLOGY, 2000, 58 (05) :946-953
[2]
Calcineurin activates NF-κB in skeletal muscle C2C12 cells [J].
Alzuherri, H ;
Chang, KC .
CELLULAR SIGNALLING, 2003, 15 (05) :471-478
[3]
Fibre-type specificity of interleukin-6 gene transcription during muscle contraction in rat: association with calcineurin activity [J].
Banzet, S ;
Koulmann, N ;
Simler, N ;
Birot, O ;
Sanchez, H ;
Chapot, R ;
Peinnequin, A ;
Bigard, X .
JOURNAL OF PHYSIOLOGY-LONDON, 2005, 566 (03) :839-847
[4]
Role of calcineurin in striated muscle: development, adaptation, and disease [J].
Bassel-Duby, R ;
Olson, EN .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 311 (04) :1133-1141
[5]
BERGMEYER HU, 1983, METHOD ENZYMAT AN, V6, P11
[6]
Calcineurin co-regulates contractile and metabolic components of slow muscle phenotype [J].
Bigard, X ;
Sanchez, H ;
Zoll, J ;
Mateo, P ;
Rousseau, V ;
Veksler, V ;
Ventura-Clapier, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (26) :19653-19660
[7]
Altering dietary nutrient intake that reduces glycogen content leads to phosphorylation of nuclear p38 MAP kinase in human skeletal muscle: association with IL-6 gene transcription during contraction [J].
Chan, MHS ;
McGee, SL ;
Watt, MJ ;
Hargreaves, M ;
Febbraio, MA .
FASEB JOURNAL, 2004, 18 (12) :1785-+
[8]
A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type [J].
Chin, ER ;
Olson, EN ;
Richardson, JA ;
Yano, Q ;
Humphries, C ;
Shelton, JM ;
Wu, H ;
Zhu, WG ;
Bassel-Duby, R ;
Williams, RS .
GENES & DEVELOPMENT, 1998, 12 (16) :2499-2509
[9]
Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease [J].
Ducreux, S ;
Zorzato, F ;
Müller, C ;
Sewry, C ;
Muntoni, F ;
Quinlivan, R ;
Restagno, G ;
Girard, T ;
Treves, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (42) :43838-43846
[10]
Muscle-derived interleukin-6: mechanisms for activation and possible biological roles [J].
Febbraio, MA ;
Pedersen, BK .
FASEB JOURNAL, 2002, 16 (11) :1335-1347